Cytometric Analysis News and Research

RSS
Gut microbiota-derived metabolites offer protection against SARS-CoV-2

Gut microbiota-derived metabolites offer protection against SARS-CoV-2

Study evaluates if adults with obesity and a history of SARS-CoV-2 infection demonstrate poorer T cell immunity

Study evaluates if adults with obesity and a history of SARS-CoV-2 infection demonstrate poorer T cell immunity

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

Analyzing transcriptomic landscape of SARS-CoV-2-infected lung cells

Analyzing transcriptomic landscape of SARS-CoV-2-infected lung cells

Study proposes SARS-CoV-2-encoded peptide presented by HLA-E may suppress inhibition of natural killer cells

Study proposes SARS-CoV-2-encoded peptide presented by HLA-E may suppress inhibition of natural killer cells

Targeting SARS-CoV-2 M protein may help ease severity of COVID-19

Targeting SARS-CoV-2 M protein may help ease severity of COVID-19

Attenuated tissue immune responses against SARS-CoV-2 in obese and non-obese patients

Attenuated tissue immune responses against SARS-CoV-2 in obese and non-obese patients

Omicron infection induces cross-reactive immune responses

Omicron infection induces cross-reactive immune responses

Discovery of diverse sarbecovirus broadly neutralizing antibodies from SARS-CoV-2 “infected-vaccinated” humans

Discovery of diverse sarbecovirus broadly neutralizing antibodies from SARS-CoV-2 “infected-vaccinated” humans

Antihistamines might be effective in long-COVID

Antihistamines might be effective in long-COVID

B.1.617.2 variant of SARS-CoV-2 is partially resistant to antibody-mediated neutralization

B.1.617.2 variant of SARS-CoV-2 is partially resistant to antibody-mediated neutralization

Highly conserved neutralizing epitope identified on SARS-CoV-2 spike protein

Highly conserved neutralizing epitope identified on SARS-CoV-2 spike protein

Study clarifies the effect of aging on hematopoietic stem cells

Study clarifies the effect of aging on hematopoietic stem cells

Most SARS-CoV-2-infected individuals develop durable B cell-mediated immunity

Most SARS-CoV-2-infected individuals develop durable B cell-mediated immunity

Novel vaccine platform against COVID-19 based on engineered human mesenchymal stem cells

Novel vaccine platform against COVID-19 based on engineered human mesenchymal stem cells

A novel approach to intraplaque mast cell characterization in atherosclerosis

A novel approach to intraplaque mast cell characterization in atherosclerosis

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab